drugset / Trial / NCT06224881

Vitamin C Deficiency in Septic Shock

NCT06224881

Phase 4 Completed 150 enrolled Cairo University
RandomizedParallel-groupOpen-labelSupportive care

Summary

Objectives: investigators aim to study the effect of addition of vitamin C as a part of treatment in septic shock patients on: Hemodynamics, Inflammation status and ICU outcome. Subjects and methods: A prospective interventional randomized cohort study, was conducted on 150 consecutive patients who were admitted to the ICU with septic shock based on SIRS, SOFA and APACHE II. Treatment group (n=75) had given ascorbic acid (Vitamin C) parenterally 6gm daily and control group (n=75). Measuring the level of Vitamin C in all study population (normal range 50-70 μM/L) before and after period of 4 days.

Timeline

Start
2021-12-01
Primary completion
2023-01-31
Completion
2023-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vitamin C Other / unclassified 2 g Intravenous